Sunday, November 17, 2024
Happening Now

Novavax offers 1st hopeful vaccine trial data vs. COVID variants

U.S. company’s vaccine shows highly promising results against U.K. variant and lower, but “still pretty good” efficacy with South Africa strain. Source

Share